Literature DB >> 27101150

RAF-1/MEK/ERK pathway regulates ATRA-induced differentiation in acute promyelocytic leukemia cells through C/EBPβ, C/EBPε and PU.1.

Xiang-Qin Weng1, Yan Sheng1, Dong-Zheng Ge2, Jing Wu1, Lei Shi1, Xun Cai3.   

Abstract

MEK/ERK signal pathway was required for the differentiation of granulocytes, megakaryocytes and erythrocytes. Recently, MEK/ERK cascade was reported to be involved in all-trans retinoic acid (ATRA) induced differentiation in acute promyelocytic leukemia (APL) cells. However, the upstream and downstream molecules of MEK/ERK signal pathway in this cell model remains to be elucidated. In this work, we showed that RAF-1 was activated and the blockade of RAF-1 activation attenuated MEK/ERK activation as well as ATRA-induced differentiation. ATRA-enhanced protein levels of C/EBPβ, C/EBPε and PU.1, which were required for differentiation in APL cells, were suppressed by the specific inhibitor of MEK. However, MEK inhibition had no effect on the degradation of PML-RARα fusion protein or the restoration of PML nuclear bodies by ATRA treatment. Taken together, our study suggested that RAF-1/MEK/ERK cascade was involved in ATRA-induced differentiation in APL cells through enhancing the protein level of C/EBPβ, C/EBPε and PU.1.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acute promyelocytic leukemia; All-trans retinoic acid; Differentiation; MEK

Mesh:

Substances:

Year:  2016        PMID: 27101150     DOI: 10.1016/j.leukres.2016.03.008

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  7 in total

1.  Enzastaurin enhances ATRA-induced differentiation of acute myeloid leukemia cells.

Authors:  Ze-Yi Li; Cui Liang; Ming Ding; Xiang-Qin Weng; Yan Sheng; Jing Wu; Hao Lu; Xun Cai
Journal:  Am J Transl Res       Date:  2020-12-15       Impact factor: 4.060

2.  A novel retinoid X receptor agonist, UAB30, inhibits rhabdomyosarcoma cells in vitro.

Authors:  Adele P Williams; Alicia M Waters; Jerry E Stewart; Venkatram R Atigadda; Elizabeth Mroczek-Musulman; Donald D Muccio; Clinton J Grubbs; Elizabeth A Beierle
Journal:  J Surg Res       Date:  2018-03-26       Impact factor: 2.192

Review 3.  Role of Vitamin A/Retinoic Acid in Regulation of Embryonic and Adult Hematopoiesis.

Authors:  Ana Cañete; Elena Cano; Ramón Muñoz-Chápuli; Rita Carmona
Journal:  Nutrients       Date:  2017-02-20       Impact factor: 5.717

4.  All-Trans Retinoic Acid Synergizes with Enasidenib to Induce Differentiation of IDH2-Mutant Acute Myeloid Leukemia Cells.

Authors:  Yundeok Kim; Hoi Kyung Jeung; June Won Cheong; Jaewoo Song; Soo Han Bae; Jong In Lee; Yoo Hong Min
Journal:  Yonsei Med J       Date:  2020-09       Impact factor: 3.052

5.  RAS-Responsive Element-Binding Protein 1 Blocks the Granulocytic Differentiation of Myeloid Leukemia Cells.

Authors:  Juanjuan Yao; Liang Zhong; Pengqiang Zhong; Dongdong Liu; Zhen Yuan; Junmei Liu; Shifei Yao; Yi Zhao; Min Chen; Lianwen Li; Lu Liu; Beizhong Liu
Journal:  Oncol Res       Date:  2019-04-08       Impact factor: 5.574

6.  The human nucleophosmin 1 mutation A inhibits myeloid differentiation of leukemia cells by modulating miR-10b.

Authors:  Qin Zou; Shi Tan; Zailin Yang; Juan Wang; Jingrong Xian; Shuaishuai Zhang; Hongjun Jin; Liyuan Yang; Lu Wang; Ling Zhang
Journal:  Oncotarget       Date:  2016-11-01

Review 7.  Current Trends in ATRA Delivery for Cancer Therapy.

Authors:  Maria Valeria Giuli; Patrizia Nadia Hanieh; Eugenia Giuliani; Federica Rinaldi; Carlotta Marianecci; Isabella Screpanti; Saula Checquolo; Maria Carafa
Journal:  Pharmaceutics       Date:  2020-07-28       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.